Delineation of regions of the Yersinia YopM protein required for interaction with the RSK1 and PRK2 host kinases and their requirement for interleukin-10 production and virulence

Infection and Immunity

Volumn 78, Issue 8, 2010, Pages 3529-3539

  McPhee, Joseph B ^a   Mena, Patricio ^a   Bliska, James B ^a  

^a STONY BROOK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 18; PHOSPHOTRANSFERASE; PROTEIN PRK 2; PROTEIN RSK 1; PROTEIN YOPM; UNCLASSIFIED DRUG; OUTER MEMBRANE PROTEIN; PROTEIN KINASE C; PROTEIN KINASE N; RPS6KA1 PROTEIN, MOUSE; S6 KINASE; VIRULENCE FACTOR; YOPM PROTEIN, YERSINIA;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; SPLEEN; VIRULENCE; YERSINIA; YERSINIA PSEUDOTUBERCULOSIS; ANIMAL; BACTERIAL COUNT; BLOOD; C57BL MOUSE; GENE DELETION; GENETICS; LYMPH NODE; METABOLISM; MICROBIOLOGY; PATHOGENICITY; PEYER PATCH; PROTEIN ANALYSIS; SURVIVAL;

ANIMALS; BACTERIAL OUTER MEMBRANE PROTEINS; COLONY COUNT, MICROBIAL; GENE DELETION; INTERFERON-GAMMA; INTERLEUKIN-10; INTERLEUKIN-18; LYMPH NODES; MICE; MICE, INBRED C57BL; PEYER'S PATCHES; PROTEIN INTERACTION MAPPING; PROTEIN KINASE C; RIBOSOMAL PROTEIN S6 KINASES, 90-KDA; SEQUENCE DELETION; SPLEEN; SURVIVAL ANALYSIS; VIRULENCE; VIRULENCE FACTORS; YERSINIA PSEUDOTUBERCULOSIS;

EID: 77955293133     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00269-10     Document Type: Article

References (50)

1. Akira, S. 2000. The role of IL-18 in innate immunity. Curr. Opin. Immunol. 12:59-63.
2. Auerbuch, V., and R. R. Isberg. 2007. Growth of Yersinia pseudotuberculosis in mice occurs independently of Toll-like receptor 2 expression and induction of interleukin-10. Infect. Immun. 75:3561-3570.
3. Autenrieth, I. B., and J. Heesemann. 1992. In vivo neutralization of tumor necrosis factor-alpha and interferon-gamma abrogates resistance to Yersinia enterocolitica infection in mice. Med. Microbiol. Immunol. 181:333-338.
4. Benabdillah, R., L. J. Mota, S. Lutzelschwab, E. Demoinet, and G. R. Cornelis. 2004. Identification of a nuclear targeting signal in YopM from Yersinia spp. Microb. Pathog. 36:247-261. (Pubitemid 38388255)
5. Black, D. S., and J. B. Bliska. 1997. Identification of p130Cas as a substrate of Yersinia YopH (Yop51), a bacterial protein tyrosine phosphatase that translocates into mammalian cells and targets focal adhesions. EMBO J. 16:2730-2744.
6. Black, D. S., and J. B. Bliska. 2000. The RhoGAP activity of the Yersinia pseudotuberculosis cytotoxin YopE is required for antiphagocytic function and virulence. Mol. Microbiol. 37:515-527.
7. Bohn, E., A. Sing, R. Zumbihl, C. Bielfeldt, H. Okamura, M. Kurimoto, J. Heesemann, and I. B. Autenrieth. 1998. IL-18 (IFN-gamma-inducing factor) regulates early cytokine production in, and promotes resolution of, bacterial infection in mice. J. Immunol. 160:299-307. (Pubitemid 28116742)
8. Boland, A., S. Havaux, and G. R. Cornelis. 1998. Heterogeneity of the Yersinia YopM protein. Microb. Pathog. 25:343-348.
9. Brubaker, R. R. 2003. Interleukin-10 and inhibition of innate immunity to yersiniae: roles of Yops and LcrV (V antigen). Infect. Immun. 71:3673-3681.
10. Chaix, J., M. S. Tessmer, K. Hoebe, N. Fuseri, B. Ryffel, M. Dalod, L. Alexopoulou, B. Beutler, L. Brossay, E. Vivier, and T. Walzer. 2008. Cutting edge: priming of NK cells by IL-18. J. Immunol. 181:1627-1631.
11. Chaturvedi, D., M. S. Cohen, J. Taunton, and T. B. Patel. 2009. The PKARI-alpha subunit of protein kinase A modulates the activation of p90RSK1 and its function. J. Biol. Chem. 284:23670-23681.
12. Datsenko, K. A., and B. L. Wanner. 2000. One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc. Natl. Acad. Sci. U. S. A. 97:6640-6645.
13. de Lorenzo, V., M. Herrero, U. Jakubzik, and K. N. Timmis. 1990. Mini-Tn5 transposon derivatives for insertion mutagenesis, promoter probing, and chromosomal insertion of cloned DNA in gram-negative eubacteria. J. Bacteriol. 172:6568-6572.
14. Depaolo, R. W., R. Tang, I. Kim, M. Han, N. Levin, N. Ciletti, A. Lin, D. Anderson, O. Schneewind, and B. Jabri. 2008. Toll-like receptor 6 drives differentiation of tolerogenic dendritic cells and contributes to LcrV-mediated plague pathogenesis. Cell Host Microbe 4:350-361.
15. Derbise, A., B. Lesic, D. Dacheux, J. M. Ghigo, and E. Carniel. 2003. A rapid and simple method for inactivating chromosomal genes in Yersinia. FEMS Immunol. Med. Microbiol. 38:113-116. (Pubitemid 37297836)
16. Dirix, V., V. Verscheure, T. Goetghebuer, M. Hainaut, A. S. Debrie, C. Locht, and F. Mascart. 2009. Monocyte-derived interleukin-10 depresses the Bordetella pertussis-specific gamma interferon response in vaccinated infants. Clin. Vaccine Immunol. 16:1816-1821.
17. Evdokimov, A. G., D. E. Anderson, K. M. Routzahn, and D. S. Waugh. 2001. Unusual molecular architecture of the Yersinia pestis cytotoxin YopM: a leucine-rich repeat protein with the shortest repeating unit. J. Mol. Biol. 312:807-821.
18. Fürste, J. P., W. Pansegrau, R. Frank, H. Blocker, P. Scholz, M. Bagdasarian, and E. Lanka. 1986. Molecular cloning of the plasmid RP4 primase region in a multi-host-range tacP expression vector. Gene 48:119-131.
19. Galyov, E. E., S. Hakansson, A. Forsberg, and H. Wolf-Watz. 1993. A secreted protein kinase of Yersinia pseudotuberculosis is an indispensable virulence determinant. Nature 361:730-732.
20. Grant, L. R., Z. J. Yao, C. M. Hedrich, F. Wang, A. Moorthy, K. Wilson, D. Ranatunga, and J. H. Bream. 2008. Stat4-dependent, T-bet-independent regulation of IL-10 in NK cells. Genes Immun. 9:316-327.
21. Hamid, N., A. Gustavsson, K. Andersson, K. McGee, C. Persson, C. E. Rudd, and M. Fallman. 1999. YopH dephosphorylates Cas and Fyn-binding protein in macrophages. Microb. Pathog. 27:231-242.
22. Hines, J., E. Skrzypek, A. V. Kajava, and S. C. Straley. 2001. Structure-function analysis of Yersinia pestis YopM's interaction with alpha-thrombin to rule on its significance in systemic plague and to model YopM's mechanism of binding host proteins. Microb. Pathog. 30:193-209.
23. Hoang, T. T., R. R. Karkhoff-Schweizer, A. J. Kutchma, and H. P. Schweizer. 1998. A broad-host-range Flp-FRT recombination system for site-specific excision of chromosomally-located DNA sequences: application for isolation of unmarked Pseudomonas aeruginosa mutants. Gene 212:77-86.
24. Jose, P., M. G. Avdiushko, S. Akira, A. M. Kaplan, and D. A. Cohen. 2009. Inhibition of interleukin-10 signaling in lung dendritic cells by Toll-like receptor 4 ligands. Exp. Lung Res. 35:1-28.
25. Kerschen, E. J., D. A. Cohen, A. M. Kaplan, and S. C. Straley. 2004. The plague virulence protein YopM targets the innate immune response by causing a global depletion of NK cells. Infect. Immun. 72:4589-4602.
26. Kim, H. M., B. S. Park, J. I. Kim, S. E. Kim, J. Lee, S. C. Oh, P. Enkhbayar, N. Matsushima, H. Lee, O. J. Yoo, and J. O. Lee. 2007. Crystal structure of the TLR4-MD-2 complex with bound endotoxin antagonist Eritoran. Cell 130:906-917.
27. Leung, K. Y., B. S. Reisner, and S. C. Straley. 1990. YopM inhibits platelet aggregation and is necessary for virulence of Yersinia pestis in mice. Infect. Immun. 58:3262-3271.
28. McCoy, M. W., M. L. Marre, C. F. Lesser, and J. Mecsas. 2010. The C-terminal tail of Yersinia YopM is critical for interacting with RSK1 and for virulence. Infect. Immun. 78:2584-2598.
29. McDonald, C., P. O. Vacratsis, J. B. Bliska, and J. E. Dixon. 2003. The Yersinia virulence factor YopM forms a novel protein complex with two cellular kinases. J. Biol. Chem. 278:18514-18523.
30. Mittal, R., S. Y. Peak-Chew, and H. T. McMahon. 2006. Acetylation of MEK2 and I kappa B kinase (IKK) activation loop residues by YopJ inhibits signaling. Proc. Natl. Acad. Sci. U. S. A. 103:18574-18579.
31. Mukherjee, S., G. Keitany, Y. Li, Y. Wang, H. L. Ball, E. J. Goldsmith, and K. Orth. 2006. Yersinia YopJ acetylates and inhibits kinase activation by blocking phosphorylation. Science 312:1211-1214.
32. Navarro, L., A. Koller, R. Nordfelth, H. Wolf-Watz, S. Taylor, and J. E. Dixon. 2007. Identification of a molecular target for the Yersinia protein kinase A. Mol. Cell 26:465-477.
33. Nemeth, J., and S. C. Straley. 1997. Effect of Yersinia pestis YopM on experimental plague. Infect. Immun. 65:924-930.
34. Palmer, L. E., S. Hobbie, J. E. Galan, and J. B. Bliska. 1998. YopJ of Yersinia pseudotuberculosis is required for the inhibition of macrophage TNF-alpha production and downregulation of the MAP kinases p38 and JNK. Mol. Microbiol. 27:953-965.
35. Perona-Wright, G., K. Mohrs, F. M. Szaba, L. W. Kummer, R. Madan, C. L. Karp, L. L. Johnson, S. T. Smiley, and M. Mohrs. 2009. Systemic but not local infections elicit immunosuppressive IL-10 production by natural killer cells. Cell Host Microbe 6:503-512.
36. Prehna, G., M. I. Ivanov, J. B. Bliska, and C. E. Stebbins. 2006. Yersinia virulence depends on mimicry of host Rho-family nucleotide dissociation inhibitors. Cell 126:869-880.
37. Shao, F., and J. E. Dixon. 2003. YopT is a cysteine protease cleaving Rho family GTPases. Adv. Exp. Med. Biol. 529:79-84.
38. Simonet, M., and S. Falkow. 1992. Invasin expression in Yersinia pseudotuberculosis. Infect. Immun. 60:4414-4417.
39. Sing, A., A. Roggenkamp, A. M. Geiger, and J. Heesemann. 2002. Yersinia enterocolitica evasion of the host innate immune response by V antigen-induced IL-10 production of macrophages is abrogated in IL-10-deficient mice. J. Immunol. 168:1315-1321.
40. Skrzypek, E., C. Cowan, and S. C. Straley. 1998. Targeting of the Yersinia pestis YopM protein into HeLa cells and intracellular trafficking to the nucleus. Mol. Microbiol. 30:1051-1065.
41. Skrzypek, E., T. Myers-Morales, S. W. Whiteheart, and S. C. Straley. 2003. Application of a Saccharomyces cerevisiae model to study requirements for trafficking of Yersinia pestis YopM in eucaryotic cells. Infect. Immun. 71: 937-947.
42. Sugawara, I. 2000. Interleukin-18 (IL-18) and infectious diseases, with special emphasis on diseases induced by intracellular pathogens. Microbes Infect. 2:1257-1263.
43. Tansini, A., and B. M. de Medeiros. 2009. Susceptibility to Yersinia pseudotuberculosis infection is linked to the pattern of macrophage activation. Scand. J. Immunol. 69:310-318.
44. Tripp, C. S., K. P. Beckerman, and E. R. Unanue. 1995. Immune complexes inhibit antimicrobial responses through interleukin-10 production. Effects in severe combined immunodeficient mice during Listeria infection. J. Clin. Invest. 95:1628-1634.
45. Trülzsch, K., T. Sporleder, E. I. Igwe, H. Russmann, and J. Heesemann. 2004. Contribution of the major secreted Yops of Yersinia enterocolitica O:8 to pathogenicity in the mouse infection model. Infect. Immun. 72:5227-5234.
46. Uff, S., J. M. Clemetson, T. Harrison, K. J. Clemetson, and J. Emsley. 2002. Crystal structure of the platelet glycoprotein Ib(alpha) N-terminal domain reveals an unmasking mechanism for receptor activation. J. Biol. Chem. 277:35657-35663.
47. r phenotypes of yersiniae. Infect. Immun. 43:895-900.
48. Viboud, G. I., and J. B. Bliska. 2005. Yersinia outer proteins: role in modulation of host cell signaling responses and pathogenesis. Annu. Rev. Microbiol. 59:69-89.
49. + cells control growth of YopM-negative Yersinia pestis during systemic plague. Infect. Immun. 77:3791-3806.
50. Zhang, Y., A. T. Ting, K. B. Marcu, and J. B. Bliska. 2005. Inhibition of MAPK and NF-kappa B pathways is necessary for rapid apoptosis in macrophages infected with Yersinia. J. Immunol. 174:7939-7949. (Pubitemid 40806304)